Display options
Cite
Agarwal S, Shlipak MG, Kramer H, et al. The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract. 2011;2012:806102doi: 10.1155/2012/806102.
Agarwal, S., Shlipak, M. G., Kramer, H., Jain, A., & Herrington, D. M. (2012). The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiology research and practice, 2012806102. https://doi.org/10.1155/2012/806102
Agarwal, Subhashish, et al. "The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis." Cardiology research and practice vol. 2012 (2012): 806102. doi: https://doi.org/10.1155/2012/806102
Agarwal S, Shlipak MG, Kramer H, Jain A, Herrington DM. The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract. 2012;2012:806102. doi: 10.1155/2012/806102. Epub 2011 Jul 26. PMID: 21860804; PMCID: PMC3154776.
Copy Download .nbib Format: NLM
Share it on

Cardiol Res Pract. 2012;2012:806102. doi: 10.1155/2012/806102. Epub 2011 Jul 26.

The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis.

Cardiology research and practice

Subhashish Agarwal, Michael G Shlipak, Holly Kramer, Aditya Jain, David M Herrington

Affiliations

  1. Cardiology Section, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

PMID: 21860804 PMCID: PMC3154776 DOI: 10.1155/2012/806102

Abstract

Background. There is an association between chronic kidney disease (CKD) and metabolic syndrome (MetS). We examined the joint association of CKD and MetS with incident cardiovascular (CVD) events in the Multiethnic Study of Atherosclerosis (MESA) cohort. Methods. We analyzed 2,283 Caucasians, 363 Chinese, 1,449 African-Americans, and 1,068 Hispanics in the MESA cohort. CKD was defined by cystatin C estimated glomerular filtration rate ≤ 60 mL/min/1.73 m(2) and MetS was defined by NCEP criteria. Cox proportional regression adjusting for age, ethnicity, gender, study site, education, income, smoking, alcohol use, physical activity, and total and LDL cholesterol was performed to assess the joint association of CKD and MetS with incident CVD events. Participants were divided into four groups by presence of CKD and/or MetS and compared to the group without CKD and MetS (CKD(-)/MetS(-)). Tests for additive and multiplicative interactions between CKD and MetS and prediction of incident CVD were performed. Results. During follow-up period of 5.5 years, 283 participants developed CVD. Multivariate Cox regression analysis demonstrated that CKD and MetS were independent predictors of CVD (hazard ratio, 2.02 for CKD, and 2.55 for MetS). When participants were compared to the CKD(-)/MetS(-) group, adjusted HR for the CKD(+)/MetS(+) group was 5.56 (95% CI 3.72-8.12). There was no multiplicative interaction between CKD and MetS (P = 0.2); however, there was presence of additive interaction. The relative excess risk for additive interaction (RERI) was 2.73, P = 0.2, and the attributable portion (AP) was 0.49 (0.24-0.74). Conclusion. Our findings illustrate that the combination of CKD and MetS is a strong predictor of incident clinical cardiovascular events due to presence of additive interaction between CKD and MetS.

References

  1. Clin Chem. 2005 Feb;51(2):321-7 - PubMed
  2. J Am Soc Nephrol. 2005 Jul;16(7):2134-40 - PubMed
  3. Ethn Dis. 2009 Autumn;19(4 Suppl 5):S5-8-11 - PubMed
  4. Pediatrics. 1998 May;101(5):875-81 - PubMed
  5. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  6. N Engl J Med. 2005 May 19;352(20):2049-60 - PubMed
  7. Am J Kidney Dis. 2008 Mar;51(3):395-406 - PubMed
  8. Mayo Clin Proc. 2005 Oct;80(10):1270-7 - PubMed
  9. JAMA. 2001 May 16;285(19):2486-97 - PubMed
  10. Int J Biochem Cell Biol. 2003 Jun;35(6):838-46 - PubMed
  11. J Nutr Metab. 2010;2010: - PubMed
  12. Am J Clin Nutr. 2004 May;79(5):820-5 - PubMed
  13. Am Heart J. 2008 Jan;155(1):62-8 - PubMed
  14. JAMA. 2005 Apr 13;293(14):1737-45 - PubMed
  15. Clin Chim Acta. 2003 Dec;338(1-2):87-90 - PubMed
  16. Circulation. 2007 Jan 16;115(2):173-9 - PubMed
  17. N Engl J Med. 2004 Sep 23;351(13):1296-305 - PubMed
  18. J Am Coll Cardiol. 2005 Jan 18;45(2):268-71 - PubMed
  19. Kidney Int. 1995 Jan;47(1):312-8 - PubMed
  20. J Am Coll Cardiol. 2007 Jan 30;49(4):403-14 - PubMed
  21. JAMA. 2002 Jan 16;287(3):356-9 - PubMed
  22. Am J Hypertens. 2010 Mar;23(3):290-8 - PubMed
  23. Clin Chem. 2001 Nov;47(11):2055-9 - PubMed
  24. J Am Soc Nephrol. 2005 Jan;16(1):180-8 - PubMed
  25. Am J Epidemiol. 2002 Nov 1;156(9):871-81 - PubMed
  26. Hypertension. 2003 Dec;42(6):1206-52 - PubMed
  27. Ann Intern Med. 2004 Feb 3;140(3):167-74 - PubMed
  28. Scand J Clin Lab Invest. 1999 Feb;59(1):1-8 - PubMed
  29. JAMA. 2002 Dec 4;288(21):2709-16 - PubMed
  30. Am J Kidney Dis. 2009 May;53(5):751-9 - PubMed
  31. Ann Epidemiol. 2007 Mar;17(3):227-36 - PubMed
  32. Circulation. 2005 Oct 25;112(17):2735-52 - PubMed
  33. Diabetologia. 2004 Feb;47(2):240-8 - PubMed

Publication Types

Grant support